Evaluating the Efficacy and Safety of Therapeutic Interventions in Sjögren's Syndrome: A Systematic Review Literature

被引:0
|
作者
Cooley, Doris E. [1 ]
Jaramillo, Arturo P. [2 ]
Armijos, Karen N. Munoz [3 ]
机构
[1] Univ Catolica Santiago de Guayaquil, Gen Dent, Guayaquil, Ecuador
[2] Univ Estatal Guayaquil, Gen Practice, Guayaquil, Ecuador
[3] Zaporozhye State Med Univ, Internal Med, Zaporozhe, Ukraine
关键词
hyposalivation; oral health; oral diseases; xerostomia; sjogren and sicca; PRIMARY SJOGRENS-SYNDROME; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; DATA-DRIVEN; CONSENSUS;
D O I
10.7759/cureus.45751
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In strict accordance with PRISMA 2020 guidelines, our research team conducted a comprehensive systematic literature review (SLR) to explore the treatment and preventive strategies for Sjogren's Syndrome (SS). Leveraging a meticulous search strategy, we scoured reputable databases such as PubMed, PubMed Central, Google Scholar, Web of Science, and The Cochrane Library. Our analysis zeroed in on 10 seminal articles that met our stringent inclusion criteria, providing a holistic view of the existing treatment landscape for SS, along with emerging diagnostic tools and associated biomarkers indicative of lymphoma risk. From a clinical standpoint, our findings unequivocally highlight the detrimental effects of SS on patients' overall well-being. Of particular interest is the growing body of evidence that underscores the effectiveness of natural remedies and over-the-counter supplements rich in antioxidants as viable therapeutic interventions. Contrary to expectations, no single laboratory marker emerged as highly sensitive for the diagnosis of SS. On a promising note, dental implants have been demonstrated to offer lasting benefits with minimal side effects, emphasizing their potential utility in enhancing the oral health of individuals affected by SS. Given the evolving nature of treatment approaches for SS, our review strongly calls for further investigations. Such research endeavors are imperative for validating the effectiveness of these treatment options, whether they serve as primary or preventive care solutions, with the overarching aim of improving the quality of oral health among those suffering from SS.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] A case of Sjögren's syndrome or multiple sclerosis? A diagnostic and therapeutic dilemma
    Bernard Thong
    N. Venketasubramanian
    Rheumatology International, 2002, 22 : 256 - 258
  • [42] Is Physical Exercise Beneficial for People with Primary Sjögren's Syndrome? Findings from a Systematic Review
    Ayan-Perez, Carlos
    Carballo-Afonso, Rocio
    Bueno-Russo, Rodrigo
    Gonzalez-Devesa, Daniel
    APPLIED SCIENCES-BASEL, 2025, 15 (03):
  • [43] Combined use of total glucosides of paeony and hydroxychloroquine in primary Sjögren's syndrome: A systematic review
    Zhang, Aiping
    Chen, Shilei
    Lin, Riyang
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (10)
  • [44] Sexual dysfunction in women with primary Sjögren's syndrome: a systematic review and meta-analysis
    Hsu, Chia-Wen
    Lee, Jian Tao
    Koo, Malcolm
    SEXUAL MEDICINE REVIEWS, 2024, 12 (03) : 299 - 306
  • [45] Association of endometriosis with Sjögren's syndrome: Genetic insights (Review)
    Zervou, Maria I.
    Tarlatzis, Basil C.
    Grimbizis, Grigoris F.
    Spandidos, Demetrios A.
    Niewold, Timothy B.
    Goulielmos, George N.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2024, 53 (02)
  • [46] Anti-Sjögren’s-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjögren's syndrome waiting to be unveiled? A case series and review of literature
    Gaurav Kumar Mittal
    Sumidha Mittal
    Harleen Kaur
    Shreya Rosa Stephen
    Shilpa Sekhar
    Sachin Sureshbabu
    Pulukool Sandhya
    Rheumatology International, 2021, 41 : 1855 - 1866
  • [47] Chemosensory dysfunction in primary Sjögren’s syndrome: a topical review
    C. Foguem
    R. Seror
    M. Gosset
    Clinical Rheumatology, 2023, 42 : 1 - 14
  • [48] The efficacy and mechanism for action of iguratimod in primary Sjögren’s syndrome patients
    Wei Jiang
    Lingshu Zhang
    Yi Zhao
    Xiong He
    Chunrong Hu
    Yi Liu
    International Ophthalmology, 2020, 40 : 3059 - 3065
  • [49] Effectiveness and safety of abatacept for the treatment of patients with primary Sjögren’s syndrome
    Adriana Cristiane Machado
    Laura Caldas dos Santos
    Tania Fidelix
    Ilda Lekwitch
    Simone Barbosa Soares
    André Felipe Gasparini
    Juliana Venturini Augusto
    Nelson Carvas Junior
    Virginia Fernandes Moça Trevisani
    Clinical Rheumatology, 2020, 39 : 243 - 248
  • [50] CLINICAL EFFICACY AND SAFETY OF THERAPEUTIC INTERVENTIONS USED IN FRIEDREICH ATAXIA: A SYSTEMATIC REVIEW
    Jain, P.
    Badgujar, L.
    Spoorendonk, J. A.
    Buesch, K.
    VALUE IN HEALTH, 2022, 25 (07) : S312 - S313